Molecule Details
InChIKeyOZVBMTJYIDMWIL-AYFBDAFISA-N
Compound NameBromocriptine
Canonical SMILESCC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)20
Pfam Stratification Homologous
Avg pChEMBL7.29
SourceBindingDB;ChEMBL
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB01200
Drug NameBromocriptine
CAS Number25614-03-3
Groups approved investigational withdrawn
ATC Codes N04BC01 G02CB01
DescriptionBromocriptine mesylate is a semisynthetic ergot alkaloid derivative with potent dopaminergic activity. It inhibits prolactin secretion and may be used to treat dysfunctions associated with hyperprolactinemia. Bromocriptine is also indicated for the management of signs and symptoms of Parkinsonian Sy...

Categories: Adrenergic Agonists Adrenergic Antagonists Adrenergic alpha-1 Receptor Agonists Adrenergic alpha-1 Receptor Antagonists Adrenergic alpha-2 Receptor Agonists Adrenergic alpha-Agonists Adrenergic alpha-Antagonists Agents producing tachycardia Agents that produce hypertension Alkaloids Anti-Dyskinesia Agents Anti-Parkinson Agents (Dopamine Agonist) Anti-Parkinson Drugs Antidepressive Agents Blood Glucose Lowering Agents Central Nervous System Agents Central Nervous System Depressants Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Dopamine Agents Dopamine Agonists Ergolines Ergot Alkaloids and Derivatives Ergot-derivative Dopamine Receptor Agonists Ergotamines Genito Urinary System and Sex Hormones Heterocyclic Compounds, Fused-Ring Hormone Antagonists Hormones, Hormone Substitutes, and Hormone Antagonists Hypotensive Agents Nervous System Neurotransmitter Agents P-glycoprotein inhibitors P-glycoprotein substrates Prolactine Inhibitors Serotonin 5-HT2 Receptor Agonists Serotonin Agents Serotonin Modulators Serotonin Receptor Agonists
Cross-references: BindingDB: 81993 ChEBI: 3181 CHEMBL493 ChemSpider: 28858 Drugs Product Database (DPD): 11220 C06856 D03165 PDB: 08Y PharmGKB: PA448671 PubChem:31101 PubChem:46505504 RxCUI: 1760 Therapeutic Targets Database: DAP001462 Wikipedia: Bromocriptine ZINC: ZINC000053683151
Target Activities (20)
Target Gene Organism Category Pfam pChEMBL Type Source
P35368 ADRA1B Homo sapiens Human PF00001 8.9 Ki BindingDB
P35462 DRD3 Homo sapiens Human PF00001 8.2 Ki ChEMBL;BindingDB
P41595 HTR2B Homo sapiens Human PF00001 8.1 Ki ChEMBL;BindingDB
P35348 ADRA1A Homo sapiens Human PF00001 8.1 Ki ChEMBL;BindingDB
P14416 DRD2 Homo sapiens Human PF00001 8.0 Ki ChEMBL;BindingDB
P28221 HTR1D Homo sapiens Human PF00001 8.0 Ki BindingDB
P08913 ADRA2A Homo sapiens Human PF00001 7.9 Ki ChEMBL;BindingDB
P25100 ADRA1D Homo sapiens Human PF00001 7.8 Ki ChEMBL;BindingDB
P50406 HTR6 Homo sapiens Human PF00001 7.7 Ki ChEMBL;BindingDB
P08908 HTR1A Homo sapiens Human PF00001 7.6 Ki ChEMBL;BindingDB
P18089 ADRA2B Homo sapiens Human PF00001 7.5 Ki ChEMBL;BindingDB
P28223 HTR2A Homo sapiens Human PF00001 7.2 Ki ChEMBL;BindingDB
P18825 ADRA2C Homo sapiens Human PF00001 7.1 Ki ChEMBL;BindingDB
P28222 HTR1B Homo sapiens Human PF00001 6.5 Ki BindingDB
P21917 DRD4 Homo sapiens Human PF00001 6.4 Ki ChEMBL;BindingDB
P21918 DRD5 Homo sapiens Human PF00001 6.3 Ki BindingDB
P28335 HTR2C Homo sapiens Human PF00001 6.3 Ki ChEMBL;BindingDB
P08588 ADRB1 Homo sapiens Human PF00001 6.2 Ki BindingDB
P21728 DRD1 Homo sapiens Human PF00001 6.2 Ki BindingDB
P07550 ADRB2 Homo sapiens Human PF00001 6.1 Ki BindingDB
DrugBank Target Actions (24)
Target Gene Target Name Action Type
P08684 CYP3A4 Cytochrome P450 3A4 inhibitor enzymes
P08684 CYP3A4 Cytochrome P450 3A4 substrate enzymes
P08908 HTR1A 5-hydroxytryptamine receptor 1A agonist targets
P08913 ADRA2A Alpha-2A adrenergic receptor agonist targets
P14416 DRD2 D(2) dopamine receptor agonist targets
P18089 ADRA2B Alpha-2B adrenergic receptor agonist targets
P18825 ADRA2C Alpha-2C adrenergic receptor agonist targets
P21728 DRD1 D(1A) dopamine receptor agonist targets
P21918 DRD5 D(1B) dopamine receptor agonist targets
P25100 ADRA1D Alpha-1D adrenergic receptor agonist targets
P28221 HTR1D 5-hydroxytryptamine receptor 1D agonist targets
P28222 HTR1B 5-hydroxytryptamine receptor 1B agonist targets
P28223 HTR2A 5-hydroxytryptamine receptor 2A agonist targets
P28335 HTR2C 5-hydroxytryptamine receptor 2C agonist targets
P35348 ADRA1A Alpha-1A adrenergic receptor agonist targets
P35368 ADRA1B Alpha-1B adrenergic receptor agonist targets
P35462 DRD3 D(3) dopamine receptor agonist targets
P41595 HTR2B 5-hydroxytryptamine receptor 2B agonist targets
P21917 DRD4 D(4) dopamine receptor antagonist targets
P34969 HTR7 5-hydroxytryptamine receptor 7 antagonist targets
P35348 ADRA1A Alpha-1A adrenergic receptor antagonist targets
P35368 ADRA1B Alpha-1B adrenergic receptor antagonist targets
P08183 ABCB1 ATP-dependent translocase ABCB1 inhibitor transporters
P08183 ABCB1 ATP-dependent translocase ABCB1 substrate transporters